Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2006, Qiming Venture Partners is a prominent venture capital firm based in China, specializing in early and growth-stage investments across technology and healthcare sectors. With a robust asset under management (AUM) of $9.5 billion spread across 18 funds, including 11 USD and 7 RMB funds, Qiming has established itself as a key player in the global venture capital landscape. The firm has invested in over 580 companies, achieving more than 210 exits and nurturing over 80 unicorns, including notable early investments in industry giants such as ByteDance, Xiaomi, Meituan, and Bilibili. Qiming's strategic focus on the Chinese market, complemented by a growing presence in the United States, allows it to leverage extensive networks and resources to support its portfolio companies effectively.
Qiming Venture Partners primarily targets early and growth-stage investments in technology and healthcare sectors, with a keen interest in artificial intelligence, robotics, semiconductors, enterprise software, consumer technology, and mobile internet. The firm typically invests between $500,000 and $34 million, with average check sizes of approximately $16.9 million for seed rounds, $23.9 million for Series A, and $34 million for Series B. While the firm has made 264 investments in China, it also maintains a secondary focus on the US market with 40 investments. Qiming seeks to partner with visionary founders and innovative companies that are poised to redefine their industries and deliver long-term societal value.
Qiming Venture Partners boasts a diverse portfolio of over 580 companies, including 13 current unicorns. Recent investments include Insight Lifetech, Z.ai, and Biren, showcasing the firm's commitment to supporting cutting-edge technology and healthcare innovations. Notable companies in Qiming's portfolio include Xiaomi, Meituan, Bilibili, Zhihu, and Cansino Biologics, reflecting the firm's strong track record in identifying and nurturing high-potential startups. With a total of 1,094 investments made to date, Qiming continues to play a pivotal role in the growth and success of its portfolio companies, driving significant value creation through strategic support and guidance.
Jianwen Chen - Co-founder and Managing Partner, with extensive experience in venture capital and a focus on technology investments.
Jing Wang - Partner, specializing in healthcare investments and strategic guidance for portfolio companies.
Yonghua Zhang - Partner, focusing on consumer technology and mobile internet sectors.
To pitch Qiming Venture Partners, founders should prepare a detailed pitch deck that highlights their business model and market potential. While specific submission guidelines are not provided, a well-structured approach is recommended. Warm introductions may be beneficial, given the firm's extensive network.
In the last 12 months, Qiming Venture Partners has made 23 investments, with the latest investment occurring on February 10, 2026. The firm continues to actively engage in the startup ecosystem, reinforcing its commitment to supporting innovative companies in technology and healthcare.
Qiming Venture Partners invests in seed, Series A, and Series B stages, focusing on early and growth-stage companies that demonstrate strong potential for innovation and market impact.
Founders interested in pitching to Qiming Venture Partners should prepare a comprehensive presentation that outlines their business model, market opportunity, and growth strategy. While specific submission guidelines are not provided, a well-structured pitch deck is essential.
Qiming Venture Partners primarily focuses on technology and healthcare sectors, with particular interest in artificial intelligence, robotics, semiconductors, enterprise software, consumer technology, and mobile internet.
The typical check size for Qiming Venture Partners ranges from $500,000 to $34 million, with average investments of approximately $16.9 million for seed rounds, $23.9 million for Series A, and $34 million for Series B.
Qiming Venture Partners primarily invests in China, with 264 investments in the region, while also engaging in the US market with 40 investments, reflecting a balanced approach to global opportunities.
Qiming Venture Partners offers extensive support to its portfolio companies, leveraging its vast network and industry expertise to help startups navigate challenges and accelerate growth.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.